Scancell (LON:SCLP) Trading 29.8% Higher – Here’s Why

Scancell Holdings plc (LON:SCLP)’s share price shot up 29.8% on Monday . The stock traded as high as GBX 11.38 ($0.15) and last traded at GBX 11 ($0.15). 10,537,342 shares changed hands during mid-day trading, an increase of 1,073% from the average session volume of 897,982 shares. The stock had previously closed at GBX 8.48 ($0.11).

Scancell Stock Down 4.9 %

The stock has a market cap of £103.47 million, a PE ratio of -15.32 and a beta of 0.35. The business has a 50 day moving average of GBX 8.51 and a 200-day moving average of GBX 10.85. The company has a current ratio of 3.42, a quick ratio of 13.01 and a debt-to-equity ratio of -566.79.

Scancell (LON:SCLP) last announced its earnings results on Thursday, January 30th. The company reported GBX (1.35) (($0.02)) EPS for the quarter. Equities research analysts predict that Scancell Holdings plc will post -2.5361112 EPS for the current fiscal year.

About Scancell

Scancell (LSE:SCLP) is a clinical stage immunotherapy biotech company developing treatments for significant unmet needs in cancer. We aim to translate our innovation and creativity into increased and durable responses in patients without compromising safety, addressing hard-to-treat cancers.

Scancell has developed a pipeline of ‘off-the-shelf’ vaccines to induce immune responses and highly tumour specific monoclonal antibodies to redirect immune cells or drugs.